Nadir Testosterone after Long-Term Followup Predicts Prognosis in Patients with Prostate Cancer Treated with Combined Androgen Blockade-Reference-Cited by-同舟云学术

Nadir Testosterone after Long-Term Followup Predicts Prognosis in Patients with Prostate Cancer Treated with Combined Androgen Blockade

Published:2015-11 Issue:5 Volume:194 Page:1264-1270
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Kamada Shuhei¹²³⁴,Sakamoto Shinichi¹²³⁴,Ando Keisuke¹²³⁴,Muroi Ayumi¹²³⁴,Fuse Miki¹²³⁴,Kawamura Koji¹²³⁴,Imamoto Takashi¹²³⁴,Suzuki Hiroyoshi¹²³⁴,Nagata Maki¹²³⁴,Nihei Naoki¹²³⁴,Akakura Koichiro¹²³⁴,Ichikawa Tomohiko¹²³⁴

Affiliation:

1. Department of Urology, Chiba University Hospital, Chiba-city, Japan

2. Department of Urology, Toho University Medical Center Sakura Hospital, Sakura, Japan

3. Department of Urology, Yokohama Rosai Hospital, Yokohama City, Japan

4. Department of Urology, Japan Community Health Care Organization Tokyo Shinjuku, Tokyo, Japan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. The relationship between total testosterone levels and prostate cancer: A review of the continuing controversy;Klap;J Urol,2015

2. Effects of serum testosterone levels after 6 months of androgen deprivation therapy on the outcome of patients with prostate cancer;Bertaglia;Clin Genitourin Cancer,2013